Drug: ALIMTA Injury: Malignant neoplasm progression Quarter: 2016Q3
Total Records: 8 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
125037392 | ALIMTA | Malignant neoplasm progression | ELI LILLY AND CO | 72.47 YR | F | 43 KG | 20160822 | JP |
125501631 | ALIMTA | Malignant neoplasm progression | ELI LILLY AND CO | 52.00 YR | F | 0 | 20160712 | JP |
126017891 | ALIMTA | Malignant neoplasm progression | ELI LILLY AND CO | 60.96 YR | F | 0 | 20160728 | US |
126154171 | ALIMTA | Malignant neoplasm progression | ELI LILLY AND CO | 68.00 YR | M | 0 | 20160802 | FR |
126747281 | ALIMTA | Malignant neoplasm progression | ELI LILLY AND CO | 69.51 YR | M | 0 | 20160822 | FR |
127665041 | ALIMTA | Malignant neoplasm progression | ELI LILLY AND CO | 53.00 YR | M | 0 | 20160921 | HK |
127750691 | ALIMTA | Malignant neoplasm progression | ELI LILLY AND CO | 74.00 YR | M | 0 | 20160923 | JP |
127855821 | ALIMTA | Malignant neoplasm progression | ELI LILLY AND CO | 67.00 YR | M | 0 | 20160927 | FR |
Total Records: 8 Number of Pages: 1